Key result
Low-dose aspirin benefits secondary prevention but offers little advantage for primary CV prevention.
Why the study?
Millions of people take low-dose aspirin daily to prevent CVD, but recent studies and guidelines indicate that few people benefit from using aspirin for primary prevention.
Novel aspirin finding in CVD prevention warrants caution; leaves open need for validation in larger trials.
Aspirin for Prevention of Cardiovascular DiseaseAspirin is sometimes used to help prevent people from developing cardiovascular disease.For different reasons, millions of people take low-dose aspirin every day.For people who have had a heart attack, a stroke, placement of a coronary artery stent, or coronary artery bypass graft surgery, there is strong evidence that aspirin helps prevent another such event.This use is called secondary prevention: making an already diagnosed disease less likely to get worse.Aspirin is also sometimes used for primary prevention: to prevent people from developing cardiovascular disease in the first place.However, recent studies and guidelines indicate that few people benefit from using aspirin in this way.Doctors recommend lowering your risk of CVD by maintaining a healthy diet, daily exercise, not smoking, and controlling cholesterol, blood pressure, and diabetes.
No takes yet. Share an insight, caveat, or question.
R. Kannan Mutharasan (2020) studied Cardiovascular disease. Aspirin was evaluated on Prevention of cardiovascular disease. Low-dose aspirin shows strong evidence for secondary prevention of cardiovascular events, but recent guidelines indicate few people benefit from its use for primary prevention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: